enterocin B

isolated from Enterococcus faecium; amino acid sequence in first source; GenBank U87997

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Desheva, Y A: 1 article (01/2019)
2.	Ermolenko, E I: 1 article (01/2019)
3.	Kolobov, A A: 1 article (01/2019)
4.	Kotyleva, M P: 1 article (01/2019)
5.	Suvorov, A N: 1 article (01/2019)
6.	Sychev, I A: 1 article (01/2019)
7.	Ahamed, Syed Ibrahim Basheer: 1 article (09/2018)
8.	Ankaiah, Dasari: 1 article (09/2018)
9.	Antonyraj, Christian Bharathi: 1 article (09/2018)
10.	Arul, Venkatesan: 1 article (09/2018)

1.	Neoplasms (Cancer) 09/01/2018 - "This is the first report that the cell growth inhibitory activity of the bacteriocin enterocin B against HeLa, HT-29 and AGS human cancer cells and this cell growth inhibitory activity was significantly increased when cancer cells treated with the heterodimer of bacteriocins enterocin-A + B. " 09/01/2018 - "Cloning, overexpression, purification of bacteriocin enterocin-B and structural analysis, interaction determination of enterocin-A, B against pathogenic bacteria and human cancer cells."
2.	Human Influenza (Influenza) 01/01/2019 - "Anti-Influenza Activity of Enterocin B In vitro and Protective Effect of Bacteriocinogenic Enterococcal Probiotic Strain on Influenza Infection in Mouse Model."
3.	Infections 01/01/2019 - "Anti-Influenza Activity of Enterocin B In vitro and Protective Effect of Bacteriocinogenic Enterococcal Probiotic Strain on Influenza Infection in Mouse Model."
4.	Hemolysis 09/01/2018 - "The bacteriocin enterocin-B, A and heterodimer of bacteriocin enterocin A + B showed no haemolysis on human RBC cells. "